Current Report Filing (8-k)
October 11 2017 - 5:02PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of report (Date of earliest event reported): October 10, 2017
Amedica
Corporation
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-33624
|
|
84-1375299
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
1885
West 2100 South
Salt
Lake City, UT
|
|
84119
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (801) 839-3500
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
5.07 Submission of Matters to a Vote of Security Holders
A
Special Meeting of Stockholders (the “Special Meeting”) of Amedica Corporation (the “Company”) was held
on October 10, 2017. At the Special Meeting, the stockholders voted on the following two proposals and cast their votes as described
below.
Proposal
No. 1
: A proposal to approve an amendment to the Company’s Restated Certificate of Incorporation to effectuate a reverse
stock split of the Company’s issued and outstanding shares of Common Stock at a ratio of between 1-for-2 and 1-for-15, inclusive,
which ratio will be selected at the sole discretion of our Board of Directors at any whole number in the above range, with any
fractional shares that would otherwise be issued as a result of the reverse stock split being rounded up to the nearest whole
share (the “Reverse Stock Split”); provided, that our Board of Directors may abandon the Reverse Stock Split in its
sole discretion. This proposal was approved.
For
|
|
Against
|
|
|
Abstain
|
|
|
Broker Non-vote
|
|
18,211,006
|
|
|
6,343,473
|
|
|
|
168,131
|
|
|
|
0
|
|
Proposal
No. 2
: A proposal to approve one or more adjournments of the special meeting, if necessary or appropriate, to solicit additional
proxies if there are insufficient votes at the time of the meeting to adopt one or more of the foregoing Proposals. This proposal
was approved.
For
|
|
Against
|
|
|
Abstain
|
|
|
Broker Non-vote
|
|
18,552,800
|
|
|
5,927,971
|
|
|
|
241,840
|
|
|
|
0
|
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
AMEDICA
CORPORATION
|
|
|
Date:
October 11, 2017
|
/s/
B. Sonny Bal
|
|
B.
Sonny Bal
President
and Chief Executive Officer
|
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Apr 2023 to Apr 2024